The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, healthy aging, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
Our opinion page features commentary from some of the best minds currently working to improve the public’s health on issues related to population health and health policy.
August 2023 Harold A. Pollack, Nate Glasser, Selwyn Rogers, Jr.,
Not long ago, some of us were asked to attend a meeting at our institution on the topic of development and employment opportunities for young people… More
July 2023 Sandro Galea,
The recent Supreme Court ruling striking down decades of race-based affirmative action in college admissions has reopened, once again, the national… More
July 2023 Morgan C. Shields, Heidi L. Allen,
Patients of inpatient psychiatry are among the most vulnerable hospital patients and have often described care experiences that were dehumanizing and… More
July 2023 Sara Rosenbaum, Kay Johnson,
Why a modern regulatory framework for EPSDT that accounts for congressional reforms to the benefit, Medicaid’s enrollment expansion, and the transition to managed care is needed. More
June 2023 John E. McDonough,
Has anti-monopoly become a bonafide political movement in the United States? About 300 persons who gathered at the Renaissance Hotel in Washington, DC, on May 4th say yes. Representing diverse organizations and backgrounds, they assembled for a daylong exploration of progress in restoring an aggressive national effort to thwart corporate monopoly across the US economy. More
June 2023 Paula M. Lantz,
The sunsetting of emergency declarations and orders, while signaling a decrease in the turmoil caused by COVID-19, does not mean the pandemic is over in the United States or globally. More
May 2023 Sandro Galea,
At some level, we failed at prevention during the COVID-19 pandemic. If our metric for success was preventing viral spread, illness, or death, then a pandemic in which the United States was hit harder than any other large country showed us that we fell substantially shorter in prevention than we might have hoped. With this as a motivating impulse, I suggest that we ask two questions: what caused the consequences of COVID-19 to be so devastating in the US? And, understanding that, what would be an intellectual and practical agenda for prevention going forward? More
May 2023 Joshua N. Auerbach, Joshua M. Sharfstein,
Two recent, much-discussed decisions from federal courts in Texas—one striking down the Affordable Care Act’s requirements for insurance coverage of preventive health services, the other invalidating the US Food and Drug Administration’s approval of the abortion drug mifepristone—illustrate a deepening tension between the public health community and the courts. Both decisions are now on appeal and may not ultimately be affirmed. More
April 2023 Dalton Conley,
Since before Ponce de Leon’s quest for the fountain of youth that led him to discover what is now Florida and Cervantes’ Don Quixote’s likeminded search, humans have sought a way to slow or even reverse the aging process. Now, however, we have preliminary evidence that there are indeed methods of slowing down senescence. More
March 2023 David Rosner,
A recent set of lawsuits against the Monsanto Corporation by local and state governments to get the company to clean up the mess it made of waterways and local schools with polychlorinated hydrocarbons (PCB) pollution has led to efforts by the company to silence scientists who have served as expert witnesses for plaintiffs. More
Get the Latest from the Milbank Memorial Fund
The Milbank Quarterly’s multidisciplinary approach and commitment to applying the best empirical research to practical policymaking offers in-depth assessments of the social, economic, political, historical, legal, and ethical dimensions of health and health care policy.